Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125820341 | 12582034 | 1 | I | 20150902 | 20160722 | 20160722 | PER | US-STRIDES ARCOLAB LIMITED-2015SP001228 | STRIDES | 0.00 | Y | 0.00000 | 20160722 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125820341 | 12582034 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, BID | 90055 | 500 | MG | ||||||||
| 125820341 | 12582034 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 90055 | ||||||||||||
| 125820341 | 12582034 | 3 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | 200 MG, QD | 0 | 200 | MG | |||||||||
| 125820341 | 12582034 | 4 | C | OSCAL /00514701/ | 2 | 1250 MG, DAILY | 0 | 1250 | MG | ||||||||||
| 125820341 | 12582034 | 5 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, DAILY | 0 | 325 | MG | |||||||||
| 125820341 | 12582034 | 6 | C | PRENATAL VITAMINS /02014401/ | VITAMINS | 1 | UNK, DAILY | 0 | |||||||||||
| 125820341 | 12582034 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 2.5 MG, QD, 2 TABS | 0 | 2.5 | MG | |||||||||
| 125820341 | 12582034 | 8 | C | BACTROBAN | MUPIROCINMUPIROCIN CALCIUM | 1 | UNK | 0 | OINTMENT, CREAM | ||||||||||
| 125820341 | 12582034 | 9 | C | CULTURELLE | LACTOBACILLUS RHAMNOSUS | 1 | 1CAPS, TID | 0 | CAPSULE | ||||||||||
| 125820341 | 12582034 | 10 | C | IMURAN | AZATHIOPRINE | 1 | 50 MG, QD | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125820341 | 12582034 | 1 | Dermatomyositis |
| 125820341 | 12582034 | 2 | Juvenile idiopathic arthritis |
| 125820341 | 12582034 | 3 | Product used for unknown indication |
| 125820341 | 12582034 | 4 | Product used for unknown indication |
| 125820341 | 12582034 | 5 | Product used for unknown indication |
| 125820341 | 12582034 | 6 | Product used for unknown indication |
| 125820341 | 12582034 | 7 | Product used for unknown indication |
| 125820341 | 12582034 | 8 | Product used for unknown indication |
| 125820341 | 12582034 | 9 | Product used for unknown indication |
| 125820341 | 12582034 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125820341 | 12582034 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125820341 | 12582034 | 1 | 201404 | 20150917 | 0 |